Chandhoke PS | StoneDisease.org

Chandhoke PS

Metabolic risk factors in patients with first-time and recurrent stone formations as determined by comprehensive metabolic evaluation.

Chandhoke PS , Fan J , Yagisawa T.

Urology. 1998 Nov;52(5):750-5.

Cost-effectiveness of different treatment options for staghorn calculi.

Chandhoke PS.

J Urol. 1996 Nov;156(5):1567-71. Comment in: J Urol. 1996 Nov;156(5):1579-80.

Read more

Efficacy and cost-effectiveness of extracorporeal shock wave lithotripsy for solitary lower pole renal calculi.

Chandhoke PS , May DJ.

J Urol. 1998 Jan;159(1):24-7

Read more

Evaluation of the recurrent stone former.

Chandhoke PS.

Urol Clin North Am. 2007 Aug;34(3):315-22.

Prevalence of metabolic stone disease in patients undergoing shockwave lithotripsy

Chandhoke PS , May DJ , Wernecke C , Manthos C , Daneshgari F.

Urolithiasis. 1996;146-7.

Read more

The information contained in the professional section of the website is intended for health care professionals in the United States only. If you are not a US health care professional, please visit the StoneDisease.org patient website.